1. Home
  2. Companies
  3. IXC
  4. Material Events

Invex Therapeutics (ASX:IXC) — Material Events

ASX:IXC · 8 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Notable 8 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Notable Score 50–74
8
Invex Therapeutics Advances Alzheimer’s Research Amid Board Shakeup and $4.5M Cash ReserveMedium
Invex Therapeutics advances Alzheimer's research collaboration, announces board changes and reports $4.5M cash at quarter end
22 Jan 2026 ·Quarterly Activities Report & Appendix 4C ·70
Invex Therapeutics Doubles Half-Year Loss Amid Progress in Alzheimer’s Drug ResearchMedium
Invex Therapeutics reports increased half-year loss, advances Exenatide research, and announces board changes
12 Feb 2026 ·Half-Year Financial Report ·70
Invex Therapeutics Suspended from ASX Over Board ShortfallHigh
Invex Therapeutics Ltd suspended from ASX for insufficient directors
7 Nov 2025 ·Suspension from Quotation ·Unexpected ·70
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.